Funding Rounds
Cimeio Therapeutics

Cimeio Therapeutics Series A (2022, $50M)

Cimeio Therapeutics

Platform for developing curative treatments for genetic diseases, blood cancers, and severe autoimmune disorders.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $50.00M

Raised Date: 2022-01-01